Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.50 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9601194 | 0.91 | ALDH1A1 (0.46) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL7788691 | 0.87 | GAA (0.49) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL7788694 | 0.87 | GAA (0.49) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| 1,4-Diallyloxybenzene SCHEMBL302448 | 0.84 | CA12 (0.63) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL3627757 | 0.84 | THRB (0.54) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL8851291 | 0.84 | MAPT (0.52) | MAPTPOLBSMN1; SMN2LMNANPC1 | |
| SCHEMBL826483 | 0.83 | CA12 (0.53) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| 1-Allyloxy-4-Ethoxybenzene SCHEMBL2846327 | 0.83 | NQO1 (0.64) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL3166393 | 0.82 | CYP1A2 (0.43) | ALDH1A1MAPTPOLBUSP2CACNA1B | |
| SCHEMBL9259951 | 0.81 | THRB (0.51) | ALDH1A1MAPTPOLBUSP2CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113817414-B | High-temperature-resistant cyanate ester insulating heat-conducting adhesive and preparation method thereof | 华东理工大学 | 2023-03-31 | — | — | CN | claimed |
| CN-113817414-A | High-temperature-resistant cyanate ester insulating heat-conducting adhesive and preparation method thereof | 华东理工大学 | 2021-12-21 | — | — | CN | claimed |
| CN-112457797-A | High-temperature-resistant cyanate ester conductive adhesive and preparation method thereof | 华东理工大学 | 2021-03-09 | — | — | CN | claimed |
| CN-119431458-A | Tungsten-oxygen complex, preparation method and application thereof in olefin oxidative cleavage and C-H bond oxidation | 江苏科技大学 | 2025-02-14 | — | — | CN | disclosed |
| US-20230322692-A1 | COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF | USA Elixiria Biotech Inc. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322692-A1 | COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF | USA Elixiria Biotech Inc. (US) | 2023-10-12 | — | — | US | disclosed |
| CN-116829526-A | Novel triallyl ether compound having triphenylalkane skeleton | 本州化学工业株式会社 | 2023-09-29 | — | — | CN | disclosed |
| US-11691953-B2 | Compound as PPAR agonist and application thereof | USA Elixiria Biotech Inc. | 2023-07-04 | — | — | US | disclosed |
| US-11691953-B2 | Compound as PPAR agonist and application thereof | USA Elixiria Biotech Inc. | 2023-07-04 | — | — | US | disclosed |
| CN-113817414-B | High-temperature-resistant cyanate ester insulating heat-conducting adhesive and preparation method thereof | 华东理工大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-115216150-A | Thermally conductive pre-applied underfill formulations and uses thereof | 汉高知识产权控股有限责任公司 | 2022-10-21 | — | — | CN | disclosed |
| EP-2199300-A2 | Peptidic compounds | The University Of Wollongong (AU) | 2010-06-23 | — | — | EP | disclosed |
| US-20080269213-A1 | 8-Hydroxyquinoline compounds and methods thereof | WYETH (US) | 2008-10-30 | — | — | US | disclosed |
| US-20080160521-A1 | BENZIMIDAZOLIUM DYES AND THEIR USE AS FLUORESCENT CHEMOSENSORS | NEW YORK UNIVERSITY (US) | 2008-07-03 | — | — | US | disclosed |
| US-20080085894-A1 | ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-04-10 | — | — | US | disclosed |
| US-7300936-B2 | α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-11-27 | — | — | US | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-6231714-B1 | BONDING PAIR OF SUBSTRATES | LOCTITE CORPORATION | 2001-05-15 | — | — | US | disclosed |
| WO-1996035760-A1 | BLEED RESISTANT CYANATE ESTER-CONTAINING COMPOSITIONS | QUANTUM MATERIALS, INC. (US) | 1996-11-14 | — | — | WO | disclosed |
| US-5447988-A | Composition for attaching semiconductor device to substrate: polycyanate ester monomer vehicle, electrically conductive filler, metal catalyst. Monomer vehicle is liquid under ambient conditions and composition is alkylphenol-free. | QUANTUM MATERIALS (US) | 1995-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691953-B2 | Compound as PPAR agonist and application thereof | PPARA, PPARG, PPARD | ALDH1A1 1114/4885MAPT 3260/4885POLB 1674/4885 |
| US-20070078120-A1 | Novel piperidine derivative | LDLR, PRMT5, MSR1 | ALDH1A1 2990/4885MAPT 4793/4885POLB 3309/4885 |
| US-20080269213-A1 | 8-Hydroxyquinoline compounds and methods thereof | MMP8, MMP26, MMP9 | ALDH1A1 406/4885MAPT 2414/4885POLB 1708/4885 |
| US-20080085894-A1 | ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS | APP, APBA1, BACE1 | ALDH1A1 1197/4885MAPT 59/4885POLB 2378/4885 |
| US-20080160521-A1 | BENZIMIDAZOLIUM DYES AND THEIR USE AS FLUORESCENT CHEMOSENSORS | IK, C9, CBR3 | ALDH1A1 760/4885MAPT 4781/4885POLB 2726/4885 |
| US-20230322692-A1 | COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF | PPARA, PPARG, PPARD | ALDH1A1 1114/4885MAPT 3260/4885POLB 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.